On the question of interstitial lung diseases in children: diffuse disorders of growth and development of the lungs

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The literature review provides current information on risk factors, clinical features, advanced diagnostic capabilities, prognosis diffuse disorders of growth and development of lung like interstitial lung disease specific to early childhood. Diffuse disorders of growth and development in children assigned to interstitial disease, due to the fact that along with anatomical defects of the lung, there is a significant increase in the interstitial tissue. Diffuse lung development disorders - acinar dysplasia, congenital alveolar dysplasia, and alveolar capillary dysplasia with misalignment of pulmonary veins is a rare condition, clinically manifested in the first hours of life, severe RDS infants, have a poor prognosis. Early diagnosis is essential for determining the management plan and prognosis of the disease. Diffuse lung disorders of growth occur in different states: bronchopulmonary dysplasia, pulmonary pathology in the neonatal period as in full-term baby so, chromosomal anomalies (trisomy 21 chromosome) and congenital heart diseases at chromosomal anomalies, and without them, congenital defects of other organs. Growth disorders formed as prenatally and postnatally and reflective of abnormalities of alveolarization. Pathology and radiology interpretation often noted the presence of emphysematous changes in these cases. The severity of the clinical course, complications, prognosis can vary in different forms. Lung growth disorders are risk factors for recurrent respiratory diseases and contribute to their chronic course.

Full Text

Restricted Access

About the authors

Evgeniya V Boitsova

First St Petersburg State Medical University

Email: evboitsova@mail.ru
MD, PhD, Dr Med Sci, Professor, Head, Laboratory of Сhildren Pulmonary

Dmitry Yu Ovsyannikov

Russian Peoples’ Friendship University

Email: mdovsyannikov@yahoo.com
MD, PhD, Dr Med Sci, Professor, Head, Department of Pediatrics

References

  1. Баранов А.А., ред., Намазова-Баранова Л.С., Давыдовой И.В., ред. Современные подходы к профилактике, диагностике и лечению бронхолегочной дисплазии: Руководство для практических врачей. - М.: Педиатрь, 2013. [Baranov AA. Ed. by LS Namazova-Baranova, IV Davydovoy. Sovremennye podkhody k profilaktike, diagnostike i lecheniyu bronkholegochnoy displazii. Rukovodstvo dlya prakticheskikh vrachey. Moscow: Pediatr; 2013. (In Russ).]
  2. Бойцова Е.В., Богданова А.В., Овсянников Д.Ю. Последствия бронхолегочной дисплазии для респираторного здоровья детей, подростков и молодых взрослых // Вопросы диагностики в педиатрии. - 2013. - Т. 5. - №1. - С. 5-11. [Boytsova EV, Bogdanova AV, Ovsyannikov DY. Posledstviya bronkholegochnoy displazii dlya respiratornogo zdorov’ya detey, podrostkov i molodykh vzroslykh. Voprosy diagnostiki v pediatrii. 2013;5(1):5-11. (In Russ).]
  3. Дегтярева Е.А., Овсянников Д.Ю., Зайцева Н.О., Шокин А.А. Легочная гипертензия и легочное сердце у детей с бронхолегочной дисплазией: факторы риска, диагностика, возможности терапии и профилактики // Педиатрия. - 2013. - Т. 92. - № 5. - С. 32-39. [Degtyareva EA, Ovsyannikov DY, Zaytseva NO, Shokin AA. Legochnaya gipertenziya i legochnoe serdtse u detey s bronkholegochnoy displaziey: faktory riska, diagnostika, vozmozhnosti terapii i profilaktiki. Pediatriya. 2013;92(5):32-39. (In Russ).]
  4. Илькович М.М., ред., Кокосов А.Н., ред. Интерстициальные заболевания легких: Руководство для врачей. - СПб.: Нормедиздат, 2005. [Ed by MM Il’kovich, AN Kokosov. Interstitsial’nye zabolevaniya legkikh. Rukovodstvo dlya vrachey. Saint Petersburg: Normedizdat; 2005. (In Russ).]
  5. Классификация клинических форм бронхолегочных заболеваний у детей. - М.: Российское респираторное общество, 2009. [Klassifikatsiya klinicheskikh form bronkholegochnykh zabolevaniy u detey. Moscow: Rossiyskoe respiratornoe obshchestvo; 2009. (In Russ).]
  6. Овсянников Д.Ю. Система оказания медицинской помощи детям, страдающим бронхолегочной дисплазией. Руководство для практикующих врачей / Ред. Л.Г. Кузьменко. - М.: МДВ, 2010. [Ovsyannikov DYu. Sistema okazaniya meditsinskoy pomoshchi detyam, stradayushchim bronkholegochnoy displaziey. Rukovodstvo dlya praktikuyushchikh vrachey. Ed. by L.G. Kuz’menko. Moscow: MDV; 2010. (In Russ).]
  7. Федоров И.А., Степанов О.Г., Пушкарева Ю.Э. Врожденная альвеолярно-капиллярная дисплазия легких у новорожденного ребенка // Вестник ЮУрГУ. - 2012. - Т. 42. - С. 127-128. [Fedorov IA, Stepanov OG, Pushkareva YE. Vrozhdennaya al’veolyarno-kapillyarnaya displaziya legkikh u novorozhdennogo rebenka. Vestnik YuUrGU. 2012;42:127-128. (In Russ).]
  8. Agrons GA, Courtney SE, Stocker JT, et al. Lung Disease in Premature Neonates: Radiologic-Pathologic Correlation. RadioGraphics. 2005;25:1047-1073. doi: 10.1148/rg.254055019.
  9. Ahmed S, Ackerman V, Faught P, et al. Profound hypoxemia and pulmonary hypertension in a 7-month-old infant: late presentation of alveolar capillary dysplasia. Pediatr Crit Care Med. 2008;9:e43-e46. doi: 10.1097/PCC.0b013e31818e383e.
  10. Al-Senan KA, Kattan A, Al-Dayel FH. Congenital acinar dysplasia. Familial cause of a fatal respiratory failure in a neonate. Saudi Med J. 2003;24:88-90.
  11. Armes JE, Ashworth M, Mifsud W. Diffuse lung disease of infancy: a pattern-based, algorithmic approach to histological diagnosis. J Clin Pathol. 2015;68:100-110. doi: 10.1136/jclinpath-2014-202685.
  12. Biko DM, Schwartz M, Anupindi SA, et al. Subpleural lung cysts in Down syndrome: prevalence and association with coexisting diagnoses. Pediatr Radiol. 2008; 38:280-4. doi: 10.1007/s00247-007-0699-3.
  13. Bishop NB, Stankiewicz P, Steinhorn RH. Alveolar Capillary Dysplasia. Am J Respir Crit Care Med. 2011;184: 172-179. doi: 10.1164/rccm.201010-1697CI.
  14. Burri PH. Structural aspects of prenatal and postnatal development and growth of the lung. In: McDonald J.A. Lung growth and development. NY: Marcel Dekker; 1997:1-35.
  15. Cooney TP, Wentworth PJ, Thurlbeck WM. Diminished radial count is found only postnatally in Down’s syndrome. Pediatr Pulmonol. 1988;5:204-209. doi: 10.1002/ppul.1950050405.
  16. Cullinane C, Cox PN, Silver MM. Persistent pulmonary hypertension of the newborn due to alveolar capillary dysplasia. Pediatr Pathol. 1992;12:499-514. doi: 10.3109/15513819209024200.
  17. Day SM, Strauss DJ, Shavelle RM, et al. Mortality and causes of death in persons with Down syndrome in California. Dev Med Child Neurol. 2005;47:171-176. doi: 10.1017/S0012162205000319.
  18. Deterding RR. Infants and young children with children’s interstitial lung disease. Pediatric Allergy, Immunology, and Pulmonology. 2010;23(1):23-31. doi: 10.1089/ped.2010.0011.
  19. Deutsch GH, Young LR, Deterding RR, et al. Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med. 2007;176(11):1120-8. doi: 10.1164/rccm.200703-393OC.
  20. Dislop MD. Diagnostic pathology of diffuse lung disease in children. Pediatric Allergy, Immunology, and Pulmonology. 2010;23(1):69-84. doi: 10.1089/ped.2010.0007.
  21. Fliman P, deRegnier R, Kinsella JP, et al. Neonatal extracorporeal life support:impact of new therapies on survival. J Pediatr. 2006;148:595-599. doi: 10.1016/j.jpeds.2005.12.024.
  22. Gillespie LM, Fenton AC, Wright C. Acinar dysplasia:a rare cause of neonatal respiratory failure. Acta Pediatr. 2004;93:712-713. doi: 10.1111/j.1651-2227.2004. tb03003.x.
  23. Gonzalez OR, Gomez IG, Recalde AL, et al. Postnatal development of the cystic lung lesion of Down syndrome: suggestion that the cause is reduced formation of peripheral air spaces. Pediatr Pathol. 1991;11:623-33. doi: 10.3109/15513819109064794.
  24. Guillerman IR. Imaging of Childhood Interstitial Lung Disease. Pediatric Allergy, Immunology, and Pulmonology. 2010;23(1):43-69. doi: 10.1089/ped.2010.0010.
  25. Husain AN, Hessel RG. Neonatal pulmonary hypoplasia: An autopsy study of 25 cases. Pediatr Pathol. 1993;13:475-84. doi: 10.3109/1551381 9309048237.
  26. Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol. 1998;29:710-717. doi: 10.1016/S0046-8177(98)90280-5.
  27. Janney CG, Askin FB, Kuhn C. Congenital alveolar capillary dysplasia- an unusual cause of respiratory distress in the newborn. Am J Clin Pathol. 1981;76:722-727. doi: 10.1093/ajcp/76.5.722.
  28. Jobe AJ. The new BPD:an arrest of lung development. Pediatr Res. 1999;46:641-643. doi: 10.1203/ 00006450-199912000-00007.
  29. Joshi VV, Kasznica J, Ali Khan MA, et al. Cystic lung disease in Down’s syndrome:a report of two cases. Pediatr Pathol. 1986;5:79-86. doi: 10.3109/15513818609068850.
  30. Kelly LK, Porta NF, Goodman DM, et al. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. J Pediatr. 2002;141:830-832. doi: 10.1067/mpd.2002.129849.
  31. Kurland G, Deterding RR, Hagood JS, et al. An Official American Thoracic Society Clinical Practice Guideline:Classification, Evaluation, and Management of Childhood Interstitial Lung Disease in Infancy. Am J Respir Crit Care Med. 2013;188(3):376-394. doi: 10.1164/rccm.201305-0923ST.
  32. Langenstroer M, Сarlan SJ, Finaian N, et al. Congenital Acinar Dysplasia: Report of a Case and Review of Literature. Am J Perinatol Rep. 2013;3:9-12. doi: 10.1055/s-0032-1329126.
  33. MacMahon HE. Congenital alveolar dysplasia of the lungs. Am J of Pathology. 1947;XXIV:919-938.
  34. Michalsky MP, Arca MJ, Groenman F, et al. Alveolar capillary dysplasia:a logical approach to a fatal disease. J Pediatr Surg. 2005;40:1100-1105. doi: 10.1016/j.jpedsurg.2005.03.067.
  35. Moerman P, Vanhole C, Devlieger H, et al. Severe primary pulmonary hypoplasia (acinar dysplasia) in sibs:a genetically determined mesodermal defect? J Med Genet. 1998;35:964-965. doi: 10.1136/jmg.35.11.964.
  36. Montgomery V, Buchino JJ. Clinical pathologic conference:a newborn infant with pulmonary hypertension. J Pediatr. 1998;133:157-161. doi: 10.1016/S0022-3476(98)70200-8.
  37. Porter HJ. Pulmonary hypoplasia. Arch Dis Child Fetal Neonatal Ed. 1999;81:81-83. doi: 10.1136/fn.81.2.F81.
  38. Rutledge JC, Jensen P. Acinar dysplasia:a new form of pulmonary maldevelopment. Hum Pathol. 1986;17:1290-1293. doi: 10.1016/S0046-8177(86)80576-7.
  39. Shehata BM, Abramowsky CR. Alveolar capillary dysplasia in an infant with trisomy 21. Pediatr Dev Pathol. 2005;8:696-700.
  40. Singh SA, Ibrahim T, Clark DJ, et al. Persistent pulmonary hypertension of newborn due to congenital capillary alveolar dysplasia. Pediatr Pulmonol. 2005;40:349-353. doi: 10.1002/ppul.20244.
  41. Stankiewicz P, Sen P, Bhatt SS, et al. Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations. Am J Hum Genet. 2009;84:780-791. doi: 10.1016/j.ajhg.2009.05.005.
  42. Steinhorn RH, Cox PN, Fineman JR, et al. Inhaled nitric oxide enhances oxygenation but not survival in infants with alveolar capillary dysplasia. J Pediatr. 1997;130: 417-422. doi: 10.1016/S0022-3476(97)70203-8.
  43. Taylor PA, Dishop MK, Lotze TE. Congenital multilobar emphysema:a characteristic lung growth disorder attributable to Filamin A gene mutations. Pediatr Radiol. 2009;39(3):S516.
  44. Thurlbeck WM, Kida K, Langston C, et al. Postnatal lung growth after repair of diaphragmatic hernia. Thorax. 1979;34(3):338-343. doi: 10.1136/thx.34.3.338.
  45. Tschanz SA, Burri PH. Postnatal lung development and its impairment by glucocorticoids. Pediatr Pulmonol Suppl. 1997;16:247-249. doi: 10.1002/ppul.19502308128.
  46. Tyrrell VJ, Asher MI, Chan Y. Subpleural lung cysts in Down’s syndrome. Pediatr Pulmonol. 1999;28:145-8. doi.org/10.1002/(SICI)1099-0496(199908)28:2 №145::AID-PPUL11>3.0.CO;2-A.
  47. Wigglesworth JS, Desai R. Is fetal respiratory function a major determinant of perinatal survival? Lancet. 1982;1:264-7. doi: 10.1016/S0140-6736(82)90986-2.
  48. Yang Q, Rasmussen SA, Friedman JM. Mortality associated with Down’s syndrome in the USA from 1983 to 1997:a population-based study. Lancet. 2002;359:1019-25. doi: 10.1016/S0140-6736(02)08092-3.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Boitsova E.V., Ovsyannikov D.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 69634 от 15.03.2021 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies